Crossmark

Angiopoietin-2 outperforms other endothelial biomarkers associated with severe acute kidney injury in patients with severe sepsis and respiratory failure

Crossref DOI link: https://doi.org/10.1186/s13054-021-03474-z

Published Online: 2021-02-04

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Wen-Kuang

McNeil, J. Brennan

Wickersham, Nancy E.

Shaver, Ciara M.

Bastarache, Julie A.

Ware, Lorraine B. http://orcid.org/0000-0002-9429-4702
Funding

Funding for this research was provided by:

National Heart, Lung, and Blood Institute (HL103836, HL135849, HL135849)

Taipei Veterans General Hospital
License Information

Text and Data Mining valid from 2021-02-04

Version of Record valid from 2021-02-04
More Information

Article History

Received: 29 September 2020

Accepted: 20 January 2021

First Online: 4 February 2021

Ethics approval and consent to participate

: The prospective study was approved by Vanderbilt Institutional Review Board (IRB #051065). Informed consent was obtained for sample collection from the patients or surrogates whenever possible; if patients or surrogates were unable to provide consent, the institutional review board granted a waiver of consent due to the minimal risk nature of the study.

: Not applicable.

: The authors declare they have no competing interests.

Document is current

Any future updates will be listed below